| http://www.w3.org/ns/prov#value | - Recruiting and retaining trial participants is now the greatest obstacle, other than funding, to developing the next generation of Alzheimer's treatments.Participation in clinical studies provides an opportunity to advance and accelerate medical research and to contribute to the better health of future generations.
|
